From the ∗Molecular Imaging Program at Stanford, Department of Radiology, School of Medicine
†Institute of Stem Cell Research and Regenerative Medicine, Stanford University, California
‡Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville
§Canary Center at Stanford for Cancer Early Detection, Department of Radiology
∥Department of Pediatrics, School of Medicine, Stanford University, California.
Received for publication September 2, 2022; and accepted for publication, after revision, November 8, 2022.
Conflicts of interest and sources of funding: This work was supported by the ReMission Alliance Against Brain Tumors and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD, grant number R01HD103638). Infrastructure support was provided by an NIH S10 Shared Instrumentation Grant (S10RR026917-01, PI Michael Moseley, PhD), the Stanford Center for Innovation in In Vivo Imaging (SCi3), the Canary Preclinical Core Imaging Facility (Canary Center at Stanford, Stanford University), and an NCI Cancer Center Support Grant (P30 CA124435-02). Dr Jianping Huang was supported by the Department of Defense (grant W81XWH-20-1-0726) for developing tumor-targeted CAR T cells. For the remaining authors, none were declared.
Correspondence to: Heike E. Daldrup-Link, MD, PhD, Molecular Imaging Program at Stanford, Stanford University, 725 Welch Road, Stanford, CA 94304. E-mail: [email protected].
Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.investigativeradiology.com).
